Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Exploring how cerebellar stimulation affects cognitive sequencing

Official title: Investigation of Cerebellar Involvement in Cognitive Sequencing

Run by Johns Hopkins University · NCT06108336 · Data updated 2026-11-12

This study is testing if stimulating a part of the brain called the cerebellum can help people improve their ability to complete tasks that require following a sequence.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment50 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 30, 2026
Study endsJuly 31, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT06108336 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are right-handed individuals aged 18-50 with at least 8 years of education who are fluent in English.

Probably not a fit

Patients with neurological disorders, psychiatric conditions, or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the role of the cerebellum in cognitive functions, particularly its involvement in sequencing tasks. By using transcranial magnetic stimulation (TMS), researchers will assess brain activation during both sequence-demanding and non-sequence-demanding tasks. The study aims to clarify how cerebellar stimulation influences cognitive processing and whether it can enhance performance in tasks that require sequencing. Participants will undergo functional MRI scans to observe brain activity in response to different stimulation conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for cognitive impairments related to sequencing and memory.

How similar studies have gone: While the role of the cerebellum in cognition is increasingly recognized, this specific approach using TMS for cognitive sequencing is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\) Age 18-50;
* 2\) educational attainment of at least 8 years;
* 3\) capable of giving informed consent;
* 4\) fluent speaker of English by self-report;
* 5\) right handed.

Exclusion Criteria:

* 1\) illicit drug use within 30 days of MRI scanning;
* 2\) neurological or systemic disorder which can cause dementia or cognitive dysfunction;
* 3\) history of an Axis I psychiatric disorder including substance use disorder;
* 4\) history of definite stroke;
* 5\) focal lesion on MRI exam;
* 6\) uncorrected visual deficits by self-report
* 7\) contraindications for MRI scanning
* 8\) use of anxiolytic, antidepressant, neuroleptic, or sedative medication
* 9\) Additional exclusion criteria recommended by Wassermann for TMS neuromodulation, including: History of seizure or a family history of epilepsy, heart disease, intracardiac lines, increased intracranial pressure, history of head trauma, and history of respiratory disease

Where it's running

  • Johns Hopkins University School of Medicine
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: John E Desmond, Ph.D. — Johns Hopkins University
  • Study coordinator: John E Desmond, Ph.D.
  • Email: jdesmon2@jhmi.edu
  • Phone: 410-502-3583

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.